Indo-Bangla Pharmaceuticals Limited (DSE:IBP)
Bangladesh · Delayed Price · Currency is BDT 13.40
+0.10 (0.75%)
At close: Mar 4, 2026
DSE:IBP Market Cap
DSE:IBP has a market cap or net worth of 1.56 billion as of March 4, 2026. Its market cap has increased by 39.58% in one year.
Market Cap
1.56B
Enterprise Value
1.57B
Revenue
198.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.40
Market Cap Chart
Since October 18, 2018, DSE:IBP's market cap has decreased from 4.00B to 1.56B, a decrease of -61.07%. That is a compound annual growth rate of -12.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 1.55B | 16.67% |
| Dec 30, 2025 | 1.32B | 22.58% |
| Dec 30, 2024 | 1.08B | -50.79% |
| Dec 28, 2023 | 2.20B | 14.55% |
| Dec 29, 2022 | 1.92B | -1.34% |
| Dec 30, 2021 | 1.94B | -7.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Asiatic Laboratories | 7.38B |
| Orion Pharma | 7.02B |
| Navana Pharmaceuticals | 6.23B |
| Techno Drugs | 3.89B |
| Ambee Pharmaceuticals | 1.80B |
| Pharma Aids | 1.67B |
| Libra Infusions | 1.42B |
| Silco Pharmaceuticals | 1.35B |